Sacubitril-valsartan: novel therapy for heart failure

Can Fam Physician. 2017 Sep;63(9):697.

Authors

Evan Sehn¹, Terrence McDonald², Adrienne J Lindblad³

Affiliations

¹ Doctor of Pharmacy student at the University of Alberta in Edmonton.
² Assistant Clinical Professor and Researcher in the Department of Family Medicine at the University of Calgary in Alberta.
³ Knowledge Translation and Evidence Coordinator with the Alberta College of Family Physicians in Edmonton.

PMID: 28904036
PMCID: PMC5597015

No abstract available

MeSH terms

Aminobutyrates / adverse effects
Aminobutyrates / therapeutic use*
Angiotensin Receptor Antagonists / adverse effects
Angiotensin Receptor Antagonists / therapeutic use*
Biphenyl Compounds
Drug Combinations
Heart Failure / blood
Heart Failure / drug therapy*
Humans
Natriuretic Peptide, Brain / blood
Tetrazoles / adverse effects
Tetrazoles / therapeutic use*
Valsartan

Substances

Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Drug Combinations
Tetrazoles
Natriuretic Peptide, Brain
Valsartan
sacubitril and valsartan sodium hydrate drug combination